Laurion Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-53,300
Closed -$4.82M 978
2019
Q3
$4.82M Sell
53,300
-35,500
-40% -$4.04M 0.04% 341
2019
Q2
$10.5M Sell
88,800
-45,100
-34% -$4.54M 0.1% 184
2019
Q1
$11.6M Buy
133,900
+111,500
+498% +$9.49M 0.16% 111
2018
Q4
$1.41M Sell
22,400
-17,600
-44% -$1.21M 0.03% 485
2018
Q3
$3.16M Buy
+40,000
New +$2.61M 0.03% 457

Other funds holding EXAS

Laurion Capital Management's EXAS Position: Q1 2026 in Review

Laurion Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 499,532 shares — an estimated $50.7M sold.

Laurion Capital Management first reported a position in EXAS in Q3 2014 and held it in 6 quarters. The position peaked at $50.7M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Laurion Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Laurion Capital Management sold 499,532 Exact Sciences shares in Q1 2026, an estimated $50.7M.
  • Laurion Capital Management first reported a position in Exact Sciences in Q3 2014 and held it in 6 quarters.
  • Laurion Capital Management's Exact Sciences position peaked at $50.7M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.